"Pfizer is looking for academic researchers who are focused on new approaches to cancer diagnoses; on tools and drugs for cardiovascular, neurodegenerative and neuropsychiatric diseases; and methods for evaluating the effectiveness of drugs. Because the agreement is flexible, researchers focused on other biomedical areas are also encouraged to submit a concept."
Does this mean Pfizer wants an inside look before they make a nice offer?